Literature DB >> 26437068

Decreased pulmonary function in asymptomatic long-term survivors after allogeneic hematopoietic stem cell transplant.

A L Oh1, P Patel1,2, K Sweiss3, R Chowdhery1, S Dudek4, D Rondelli1,2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26437068     DOI： 10.1038/bmt.2015.216

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

2.  Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.

Authors:  O Ringdén; M Remberger; T Ruutu; J Nikoskelainen; L Volin; L Vindeløv; T Parkkali; S Lenhoff; B Sallerfors; L Mellander; P Ljungman; N Jacobsen
Journal:  Blood       Date:  1999-04-01       Impact factor: 22.113

3.  Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

Authors:  Jeanne Palmer; Kirsten Williams; Yoshihiro Inamoto; Xiaoyu Chai; Paul J Martin; Linus Santo Tomas; Corey Cutler; Daniel Weisdorf; Brenda F Kurland; Paul A Carpenter; Joseph Pidala; Steven Z Pavletic; William Wood; David Jacobsohn; Sally Arai; Mukta Arora; Madan Jagasia; Georgia B Vogelsang; Stephanie J Lee
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-04       Impact factor: 5.742

Review 4.  Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment.

Authors:  Andrea Bacigalupo; Jason Chien; Giovanni Barisione; Steven Pavletic
Journal:  Semin Hematol       Date:  2012-01       Impact factor: 3.851

5.  Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

Authors:  Kirsten M Williams; Jason W Chien; Mark T Gladwin; Steven Z Pavletic
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

6.  Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation.

Authors:  T K Marras; C K Chan; J H Lipton; H A Messner; J P Szalai; A Laupacis
Journal:  Bone Marrow Transplant       Date:  2004-03       Impact factor: 5.483

7.  Fludarabine/i.v. BU conditioning regimen: myeloablative, reduced intensity or both?

Authors:  S Chunduri; L C Dobogai; D Peace; Y Saunthararajah; J Quigley; Y-H Chen; N Mahmud; E Hurter; R Beri; D Rondelli
Journal:  Bone Marrow Transplant       Date:  2008-02-11       Impact factor: 5.483

8.  Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect.

Authors:  Emiko Sakaida; Chiaki Nakaseko; Akane Harima; Akira Yokota; Ryuko Cho; Yasushi Saito; Miki Nishimura
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

9.  Decreased lung function in one year survivors of allogeneic bone marrow transplantation conditioned with high-dose busulphan and cyclophosphamide.

Authors:  M B Lund; J Kongerud; L Brinch; S A Evensen; J Boe
Journal:  Eur Respir J       Date:  1995-08       Impact factor: 16.671

Review 10.  Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.

Authors:  G C Hildebrandt; T Fazekas; A Lawitschka; H Bertz; H Greinix; J Halter; S Z Pavletic; E Holler; D Wolff
Journal:  Bone Marrow Transplant       Date:  2011-03-28       Impact factor: 5.483
View more
  2 in total

1.  Pediatric Hematopoietic Cell Transplant Patients Who Survive Critical Illness Frequently Have Significant but Recoverable Decline in Functional Status.

Authors:  Matt S Zinter; Richard Holubkov; Martina A Steurer; Christopher C Dvorak; Christine N Duncan; Anil Sapru; Robert F Tamburro; Patrick S McQuillen; Murray M Pollack
Journal:  Biol Blood Marrow Transplant       Date:  2017-11-08       Impact factor: 5.742

2.  Functional capacity, pulmonary function, and quality of life in hematopoietic stem cell transplantation survivors.

Authors:  Giana Berleze Penna; Tassiana Costa da Silva; Alessandra Aparecida Paz; Bruna Ziegler
Journal:  Support Care Cancer       Date:  2021-01-04       Impact factor: 3.359
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.